Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 278

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation

Open access
Kudo, Yotaro, Tateishi, Keisuke, Yamamoto, Keisuke, Yamamoto, Shinzo, Asaoka, Yoshinari, Ijichi, Hideaki, Nagae, Genta, Yoshida, Haruhiko, Aburatani, Hiroyuki, Koike, Kazuhiko·2012·Cancer Science

Abstract

Dysregulated DNA methylation followed by abnormal gene expression is an epigenetic hallmark in cancer. DNA methylation is catalyzed by DNA methyltransferases, and the aberrant expression or mutations of DNA methyltransferase genes are found in human neoplasm. The enzymes for demethylating 5‐methylcytosine were recently identified, and the biological significance of DNA demethylation is a current focus of scientific attention in various research fields. Ten–eleven translocation (TET) proteins have an enzymatic activity for the conversion from 5‐methylcytosine to 5‐hydroxymethylcytosine (5‐hm C), which is an intermediate of DNA demethylation. The loss‐of‐function mutations of TET2 gene were reported in myeloid malignancies, suggesting that impaired TET‐mediated DNA demethylation could play a crucial role in tumorigenesis. It is still unknown, however, whether DNA demethylation is involved in biological properties in solid cancers. Here, we show the loss of 5‐hm C in a broad spectrum of solid tumors: for example, a significant reduction of 5‐hm C was found in 72.7% of colorectal cancers (CRCs) and 75% of gastric cancers compared to background tissues. TET1 expression was decreased in half of CRC s, and a large part of them was followed by the loss of 5‐hm C. These findings suggest that the amount of 5‐hm C in tumors is often reduced via various mechanisms, including the downregulation of TET1. Consistently, in the in vitro experiments, the downregulation of TET1 was clearly induced by oncogene‐dependent cellular transformation, and loss of 5‐hm C was seen in the transformed cells. These results suggest the critical roles of aberrant DNA demethylation for oncogenic processes in solid tissues. (Cancer Sci 2012; 103: 670–676)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1349-7006.2012.02213.x

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 278

Metadata

Authors
Kudo, Y., Tateishi, K., Yamamoto, K., Yamamoto, S., Asaoka, Y., Ijichi, H., Nagae, G., Yoshida, H., Aburatani, H., & Koike, K.
Venue
Cancer Science
Publisher
Wiley
Published
2012-02-27
Volume
103
Issue
4
Pages
670-676
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W2030406772
Cited by
278
References
39
FWCI
10.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation. https://app.cochat.ai/papers/10.1111/j.1349-7006.2012.02213.x
The paper
Kudo, Y., Tateishi, K., Yamamoto, K., Yamamoto, S., Asaoka, Y., Ijichi, H., Nagae, G., Yoshida, H., Aburatani, H., & Koike, K. (2012). Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Science. https://doi.org/10.1111/j.1349-7006.2012.02213.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.